<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cells</journal-id><journal-id journal-id-type="iso-abbrev">Cells</journal-id><journal-id journal-id-type="publisher-id">cells</journal-id><journal-title-group><journal-title>Cells</journal-title></journal-title-group><issn pub-type="epub">2073-4409</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3972685</article-id><article-id pub-id-type="doi">10.3390/cells2020224</article-id><article-id pub-id-type="publisher-id">cells-02-00224</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Temporal Gene Expression Kinetics for Human Keratinocytes Exposed to Hyperthermic Stress </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Echchgadda</surname><given-names>Ibtissam</given-names></name><xref ref-type="aff" rid="af1-cells-02-00224">1</xref><xref ref-type="aff" rid="af2-cells-02-00224">2</xref></contrib><contrib contrib-type="author"><name><surname>Roth</surname><given-names>Caleb C.</given-names></name><xref ref-type="aff" rid="af3-cells-02-00224">3</xref></contrib><contrib contrib-type="author"><name><surname>Cerna</surname><given-names>Cesario Z.</given-names></name><xref ref-type="aff" rid="af4-cells-02-00224">4</xref></contrib><contrib contrib-type="author"><name><surname>Wilmink</surname><given-names>Gerald J.</given-names></name><xref ref-type="aff" rid="af1-cells-02-00224">1</xref><xref rid="c1-cells-02-00224" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-cells-02-00224"><label>1 </label>Air Force Research Laboratory, 711th Human Performance Wing, Human Effectiveness Directorate, Bioeffects Division, Radio Frequency Bioeffects Branch, 4141 Petroleum Road, Bldg. 3260, Fort Sam Houston, TX 78234, USA; E-Mail: <email>ibtissam.echchgadda.ctr@mail.mil</email></aff><aff id="af2-cells-02-00224"><label>2 </label>National Academy of Sciences NRC Research Associateship, Fort Sam Houston, TX 78234, USA</aff><aff id="af3-cells-02-00224"><label>3 </label>Department of Radiology, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA; E-Mail: <email>rothc@livemail.uthscsa.edu</email></aff><aff id="af4-cells-02-00224"><label>4 </label>General Dynamics Information Technology, Fort Sam Houston, TX 78234, USA; E-Mail: <email>cesario.z.cerna.ctr@mail.mil</email></aff><author-notes><corresp id="c1-cells-02-00224"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>gerald.j.wilmink.civ@mail.mil</email>; Tel.: +1-210-539-8004; Fax: +1-210-539-7945.</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2013</year></pub-date><volume>2</volume><issue>2</issue><fpage>224</fpage><lpage>243</lpage><history><date date-type="received"><day>28</day><month>2</month><year>2013</year></date><date date-type="rev-recd"><day>29</day><month>3</month><year>2013</year></date><date date-type="accepted"><day>02</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>© 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>The gene expression kinetics for human cells exposed to hyperthermic stress are not well characterized. </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we identified and characterized the genes that are differentially expressed in human epidermal keratinocyte (HEK) cells exposed to hyperthermic stress. </plain></SENT>
<SENT sid="3" pm="."><plain>In order to obtain temporal gene expression kinetics, we exposed HEK cells to a heat stress protocol (44 °C for 40 min) and used messenger RNA (mRNA) microarrays at 0 h, 4 h and 24 h post-exposure. </plain></SENT>
<SENT sid="4" pm="."><plain>Bioinformatics software was employed to characterize the chief biological processes and canonical pathways associated with these heat stress genes. </plain></SENT>
<SENT sid="5" pm="."><plain>The data shows that the genes encoding for heat shock proteins (HSPs) that function to prevent further protein denaturation and aggregation, such as HSP40, HSP70 and HSP105, exhibit maximal expression immediately after exposure to hyperthermic stress. </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the smaller HSPs, such as HSP10 and HSP27, which function in mitochondrial protein biogenesis and cellular adaptation, exhibit maximal expression during the “recovery phase”, roughly 24 h post-exposure. </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that the temporal expression kinetics for each particular HSP appears to correlate with the cellular function that is required at each time point. </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, these data provide additional insight regarding the expression kinetics of genes that are triggered in HEK cells exposed to hyperthermic stress. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>keratinocytes</kwd><kwd>heat shock</kwd><kwd>gene expression</kwd><kwd>cellular stress response</kwd><kwd>bioinformatics</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec><title><text><SENT sid="9" pm="."><plain>1. </plain></SENT>
<SENT sid="10" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="11" pm="."><plain>Human beings frequently encounter a wide variety of hyperthermic stressors. </plain></SENT>
<SENT sid="12" pm="."><plain>Common examples include exposure to hot conducting objects, elevated environmental temperatures, as well as electromagnetic radiation from the sun and numerous man-made sources, such as lasers, communication devices and imaging systems [1,2,3,4,5,6,7,8,9,10]. </plain></SENT>
<SENT sid="13" pm="."><plain>The heat generated by hyperthermic stressors can be harmful to organisms, because it can temporarily or permanently alter the conformation and function of vital intracellular biomacromolecules (i.e., lipids, proteins and nucleic acids). </plain></SENT>
<SENT sid="14" pm="."><plain>Such modifications can result in an array of damaging effects, including cellular morphological alterations (i.e., shape, size, irregularities and roughness), cytoskeleton restructuring, organelle reorganization and/or fragmentation and direct interference with intracellular transport processes [11]. </plain></SENT>
</text></p><p><text><SENT sid="15" pm="."><plain>Hyperthermic effects can interfere with an organism’s normal homeostasis, and thus, if they are not adequately counteracted, they can threaten its survival. </plain></SENT>
<SENT sid="16" pm="."><plain>In order to survive and minimize the effects of hyperthermic stress, virtually all cells in living organisms have evolved sophisticated sensing, response and adaptation mechanisms. </plain></SENT>
<SENT sid="17" pm="."><plain>The crux of these mechanisms is the molecular defense reaction, most commonly referred to as the cellular stress response (CSR). </plain></SENT>
<SENT sid="18" pm="."><plain>The CSR is immediately activated in response to stress stimuli, and a hallmark of this response is the robust transcriptional expression of hundreds of diverse genes. </plain></SENT>
<SENT sid="19" pm="."><plain>These genes encode for a multitude of proteins involved in many important functions, including cellular survival, deoxyribonucleic acid (DNA) sensing and repair, redox regulation, proteolysis, molecular chaperoning, cell cycle control and apoptosis [12,13]. </plain></SENT>
<SENT sid="20" pm="."><plain>Furthermore, each CSR gene exhibits unique expression profiles, which differ in magnitude, onset time and duration of expression [4,10]. </plain></SENT>
</text></p><p><text><SENT sid="21" pm="."><plain>The epidermis, the outermost layer of an organism’s skin, regularly encounters a wide variety of stressors. </plain></SENT>
<SENT sid="22" pm="."><plain>In fact, the primary function of the epidermis is to give organisms a physiological protection barrier against environmental stimuli, such as hyperthermic stressors. </plain></SENT>
<SENT sid="23" pm="."><plain>This protective role is mediated primarily by keratinocytes, the predominant epithelial cell type (~95%). </plain></SENT>
<SENT sid="24" pm="."><plain>Due to their anatomical location, keratinocytes are habitually exposed to environmental temperature variations, and thus, they are the primary and frequent target of hyperthermic stress. </plain></SENT>
<SENT sid="25" pm="."><plain>In addition, their frequent exposure to heat stress has also been reported to render them with specialized cellular responses, which make them more resistant to stress than virtually all other cell types [14,15]. </plain></SENT>
<SENT sid="26" pm="."><plain>Clearly, keratinocytes carry a disproportionate burden in maintaining homeostasis for organisms; thus, they are vital players in sensing, responding and adapting to the burdens of hyperthermic stress. </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>Over the past decade, numerous microarray experiments have been performed to better understand the stress response of human epidermal keratinocytes (HEK) [15,16,17,18,19]. </plain></SENT>
<SENT sid="28" pm="."><plain>These studies have been particularly fruitful, because they have resulted in the identification of hundreds of stress-inducible genes. </plain></SENT>
<SENT sid="29" pm="."><plain>However, previous gene expression studies have failed to provide a comprehensive picture of the cellular stress response for several reasons. </plain></SENT>
<SENT sid="30" pm="."><plain>First, the microarray gene chips utilized in most of the previous studies were incomplete and, thus, provided expression kinetics for only a fraction of the genes in the human genome. </plain></SENT>
<SENT sid="31" pm="."><plain>Second, many previous studies made gene expression measurements at a single time point; as a result, temporal gene expression kinetics could not be ascertained. </plain></SENT>
<SENT sid="32" pm="."><plain>Finally, the majority of past studies examined the response of skin cells to ultraviolet stress; however, few studies have specifically analyzed the transcriptional response of HEK to hyperthermic stress [10]. </plain></SENT>
</text></p><p><text><SENT sid="33" pm="."><plain>In this study, we sought to identify and characterize the genes that are differentially expressed in HEK exposed to hyperthermic stress. </plain></SENT>
<SENT sid="34" pm="."><plain>To obtain temporal gene expression kinetics, we exposed HEK to a heat stress protocol (44 °C for 40 min) and used mRNA microarrays at three time points: 0 h, 4 h and 24 h post-heat treatment, as outlined in Figure 1A. </plain></SENT>
<SENT sid="35" pm="."><plain>Then, we used bioinformatics software to characterize the chief biological processes and canonical pathways associated with these genes. </plain></SENT>
<SENT sid="36" pm="."><plain>These data provide valuable new insights that give us a much clearer picture of the genes and intracellular signaling pathways that are triggered in human cells exposed to hyperthermic stress. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f001" position="float"><label>Figure 1</label><caption><p><text><SENT sid="37" pm="."><plain>(A) A schematic of the heat shock exposure protocol and post analysis techniques. </plain></SENT>
<SENT sid="38" pm="."><plain>(B) Cellular MTT viability for keratinocytes exposed to hyperthermic stress. </plain></SENT>
<SENT sid="39" pm="."><plain>Viability percentage data (relative to untreated samples) was measured for wells with concentration densities ranging from 10,000 to 100,000 cells per well. </plain></SENT>
<SENT sid="40" pm="."><plain>Viability was measured at 0, 4 and 24 h post-heat treatment. </plain></SENT>
<SENT sid="41" pm="."><plain>(C) Microarray global gene expression profiles. </plain></SENT>
<SENT sid="42" pm="."><plain>The data shows that 762, 1,422 and 1,478 total genes were differentially expressed at 0, 4 and 24 h post-exposure, respectively. </plain></SENT>
<SENT sid="43" pm="."><plain>(D) Gene expression for minimal stress protein, heat shock protein 70 (HSPA6) using qRT-PCR. </plain></SENT>
<SENT sid="44" pm="."><plain>The mRNA expression fold values were measured for sham and heat treatment groups. </plain></SENT>
<SENT sid="45" pm="."><plain>For each time point, three samples (S1, S2 and S3) were assessed, each in triplicates. </plain></SENT>
<SENT sid="46" pm="."><plain>Values were calculated in relation to β-actin and normalized to a separate RNA calibrator. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g001"/></fig></SecTag></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec><title><text><SENT sid="47" pm="."><plain>2. </plain></SENT>
<SENT sid="48" pm="."><plain>Results and Discussion </plain></SENT>
</text></title><sec><title><text><SENT sid="49" pm="."><plain>2.1. </plain></SENT>
<SENT sid="50" pm="."><plain>Keratinocytes Induce an Appreciable Stress Response When Exposed To Hyperthermic Stress </plain></SENT>
</text></title><p><text><SENT sid="51" pm="."><plain>We conducted an initial set of experiments to investigate the impact that our selected hyperthermia stress protocol had on cellular viability. </plain></SENT>
<SENT sid="52" pm="."><plain>For these studies, HEKs were exposed to hyperthermic stress and cellular metabolic activity was measured at 0, 4 and 24 h post-exposure using MTT assays (Figure 1B). </plain></SENT>
<SENT sid="53" pm="."><plain>For all cell densities tested, the data shows that greater than 90% of the cells survive after being exposed to our hyperthermic stress protocol. </plain></SENT>
<SENT sid="54" pm="."><plain>This data confirms that the HEKs cells were viable post-heat exposure. </plain></SENT>
</text></p><p><text><SENT sid="55" pm="."><plain>After confirming that the HEK cells survived post-exposure, we then sought to test whether our selected hyperthermic stress protocol induced an appreciable transcriptional stress response To investigate the transcriptional stress response, we exposed HEK cells to hyperthermic stress and used microarray gene chips to quantify the expression level of genes at 0, 4 and 24 h post-exposure (Figure 1A). </plain></SENT>
<SENT sid="56" pm="."><plain>Since a signature feature of an appreciable stress response is the rapid and marked upregulation of minimal stress genes [12], we conducted microarray and PCR analyses to examine the genes that HEKs express when exposed to hyperthermia (Figure 1C,D). </plain></SENT>
<SENT sid="57" pm="."><plain>Using Ingenuity Pathway Analysis (IPA) software, we filtered the microarray data using the following cut-offs: (i) an absolute value of expression magnitude (log2 ratio relative to control) greater or equal to 1.5; and (ii) a p-value less than or equal to 0.05. </plain></SENT>
<SENT sid="58" pm="."><plain>Of the 54,675 probe sets tested on each gene chip, we found that 762, 1,422 and 1,478 genes were differentially expressed at the 0, 4 and 24 h time points, respectively (Figure 1C). </plain></SENT>
<SENT sid="59" pm="."><plain>The number of upregulated genes increased in a logarithmic fashion from 466 at 0 h, 872 at 4 h and up to 1,127 at 24 h. </plain></SENT>
<SENT sid="60" pm="."><plain>Interestingly, roughly 60% of the transcripts regulated at 0 and 4 h were upregulated, but by 24 h, ~75% of the differentially expressed genes were upregulated. </plain></SENT>
</text></p><p><text><SENT sid="61" pm="."><plain>Specifically, we found that the heat-treated groups expressed transcripts for many heat shock proteins (Hsps). </plain></SENT>
<SENT sid="62" pm="."><plain>We also found that the transcripts encoding for heat shock protein 70 (HSPA6) exhibited the greatest increase in expression and the highest level of statistical significance. </plain></SENT>
<SENT sid="63" pm="."><plain>To validate these microarray results, we then conducted qRT-PCR analyses for HSPA6 (Hsp70) (Figure 1D). </plain></SENT>
<SENT sid="64" pm="."><plain>For all of the samples tested, we found that the heat-treated treatment group exhibited statistically significant increases in HSPA6 expression, ranging between 10- and 25-fold compared to the sham group. </plain></SENT>
<SENT sid="65" pm="."><plain>These results were consistent with the microarray data, which showed that HSPA6 expression increased between 4- and 32-fold. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="66" pm="."><plain>2.2. </plain></SENT>
<SENT sid="67" pm="."><plain>Temporal Gene Expression Profiles for Keratinocytes Exposed To Hyperthermic Stress </plain></SENT>
</text></title><p><text><SENT sid="68" pm="."><plain>In order to visualize the global distribution of the gene expression profiles, we then created volcano plots for all genes at each time point. </plain></SENT>
<SENT sid="69" pm="."><plain>In these plots, the level of statistical significance (p-value) for each gene is plotted versus the fold-change in expression level relative to untreated sham (Figure 2). </plain></SENT>
<SENT sid="70" pm="."><plain>Genes with the highest level of statistical significance appear on the right side of the plot. </plain></SENT>
<SENT sid="71" pm="."><plain>In addition, upregulated genes that display large-magnitude fold-changes appear towards the top of the plot (denoted with green triangles), whereas downregulated genes appear towards the bottom (denoted with red triangles). </plain></SENT>
<SENT sid="72" pm="."><plain>We found that considerably more genes were differentially expressed at 4 h and 24 h than at the 0 h time point. </plain></SENT>
<SENT sid="73" pm="."><plain>We also found that the transcripts expressed at the later time points also exhibited lower p-values and larger-magnitude changes in expression level than the genes at 0 h. </plain></SENT>
<SENT sid="74" pm="."><plain>Collectively, our results show that hyperthermic stress triggers a rapid, robust and extensive transcriptional response in HEK cells. </plain></SENT>
<SENT sid="75" pm="."><plain>The temporal kinetics expression data also show that this stress response is immediately activated in response to stress and is sustained for many hours after exposure. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f002" position="float"><label>Figure 2</label><caption><p><text><SENT sid="76" pm="."><plain>Volcano plots of the gene expression profiles at each time point. </plain></SENT>
<SENT sid="77" pm="."><plain>The magnitude of differential expression (log2 fold-change) is plotted versus the level of statistical significance (p-value) of all genes in the microarray for 0, 4 and 24 h post-heat exposure. </plain></SENT>
<SENT sid="78" pm="."><plain>Upregulated and downregulated genes with absolute log2 ratios ≥1.5 and p-values ≤0.05 are depicted with green and red triangle symbols, respectively. </plain></SENT>
<SENT sid="79" pm="."><plain>Insignificant genes are denoted with light gray symbols. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g002"/></fig></SecTag></sec><sec><title><text><SENT sid="80" pm="."><plain>2.3. </plain></SENT>
<SENT sid="81" pm="."><plain>Biological Functions of Heat-Shock-Induced Genes </plain></SENT>
</text></title><p><text><SENT sid="82" pm="."><plain>After identifying the genes expressed in response to hyperthermic stress, we then used IPA software to identify each gene’s primary biological functions. Figure 3 contains pie charts of the total number of genes associated with each cellular and molecular function. </plain></SENT>
<SENT sid="83" pm="."><plain>We found that 23 biological functions were common to all three time points. </plain></SENT>
<SENT sid="84" pm="."><plain>Interestingly, only nine functions in this group were either unique to one or shared by two time points (Figure 3). </plain></SENT>
<SENT sid="85" pm="."><plain>In general, the 0 h and 24 h time points share many genes with functions required for free radical scavenging, whereas only the 4 h time point contains genes with functions dedicated primarily to protein regulation (i.e., protein trafficking and protein folding) (Figure 3B). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f003" position="float"><label>Figure 3</label><caption><p><text><SENT sid="86" pm="."><plain>Diagrams of cellular and molecular functions associated with genes expressed in human epidermal keratinocyte (HEK) cells exposed to heat shock. </plain></SENT>
<SENT sid="87" pm="."><plain>Following an Ingenuity Pathway Analysis (IPA) core analysis, the molecular and cellular functions linked to each recovery period were sorted and illustrated. </plain></SENT>
<SENT sid="88" pm="."><plain>(A) A list of the 23 biological functions common to all three time points and nine functions unique to one time point or shared between two time points; (B) Pie charts of gene functions at 0, 4 and 24 h post-exposure. </plain></SENT>
<SENT sid="89" pm="."><plain>The pie chart sectors represent the number of genes associated with each function. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g003"/></fig></SecTag><p><text><SENT sid="90" pm="."><plain>Next, we identified the biological function groups that had the greatest number of differentially expressed genes. </plain></SENT>
<SENT sid="91" pm="."><plain>For each time point, we generated color-coded pie charts containing the top five biological functions and the number of genes in each group (Figure 4). </plain></SENT>
<SENT sid="92" pm="."><plain>We found that two biological functions (i.e., cellular growth and proliferation and cell death) appeared in the top five at each time point. </plain></SENT>
<SENT sid="93" pm="."><plain>In addition to these functions, the 0 h and 4 h time points also shared two more top functions, which are associated with cellular development and gene expression. </plain></SENT>
<SENT sid="94" pm="."><plain>The only major difference between these time points was that the 0 h time point had more genes associated with molecular transport, whereas the 4 h group had more genes involved in cellular movement functions. </plain></SENT>
<SENT sid="95" pm="."><plain>In contrast, despite exhibiting a similar number of regulated genes, the 4 h and 24 h groups only shared three top functions: cellular movement, cell death and cell growth. </plain></SENT>
<SENT sid="96" pm="."><plain>The primary difference between these time points is that the 4 h group had more genes dedicated to cellular development and gene expression, whereas the 24 h group exhibited genes with cellular function and cell cycle processes. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f004" position="float"><label>Figure 4</label><caption><p><text><SENT sid="97" pm="."><plain>Pie chart of the top five cellular and molecular functions at each time point. </plain></SENT>
<SENT sid="98" pm="."><plain>Each sector of the pie chart represents the total number of genes expressed for each cellular function. </plain></SENT>
<SENT sid="99" pm="."><plain>Genes were filtered for an absolute value log2 ratio ≥1.5 and a significance value of p ≤ 0.05. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g004"/></fig></SecTag></sec><sec><title><text><SENT sid="100" pm="."><plain>2.4. </plain></SENT>
<SENT sid="101" pm="."><plain>Identification of Shared and Unique Genes </plain></SENT>
</text></title><p><text><SENT sid="102" pm="."><plain>We next sought to determine whether any of the differentially expressed genes were observed at all time points. </plain></SENT>
<SENT sid="103" pm="."><plain>To answer this question, we performed a biomarker filter analysis. </plain></SENT>
<SENT sid="104" pm="."><plain>This tool allowed us to identify the genes that were unique and shared by each group. </plain></SENT>
<SENT sid="105" pm="."><plain>The Venn diagram in Figure 5 shows the total number of genes that were shared and unique to each time point. </plain></SENT>
<SENT sid="106" pm="."><plain>A total of 492, 1,066 and 1,142 genes were unique to the 0 h, 4 h and 24 h evaluation groups, respectively. </plain></SENT>
<SENT sid="107" pm="."><plain>We found that 121 genes were common to both the 0 h and 4 h, 107 genes to the 0 h and 24 h and 183 genes to the 4 h and 24 h. </plain></SENT>
<SENT sid="108" pm="."><plain>Notably, only 50 genes were shared among all three recovery time points. </plain></SENT>
<SENT sid="109" pm="."><plain>A comprehensive list of these genes is provided as supplementary material (Supplementary Tables 1–6). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f005" position="float"><label>Figure 5</label><caption><p><text><SENT sid="110" pm="."><plain>Identification of unique and shared genes. </plain></SENT>
<SENT sid="111" pm="."><plain>The Venn diagram indicates the number of unique and common differentially expressed genes at each time point. </plain></SENT>
<SENT sid="112" pm="."><plain>Biomarker comparison analysis was performed in IPA. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g005"/></fig></SecTag><p><text><SENT sid="113" pm="."><plain>After identifying the 50 genes that were expressed at each time point, we then performed a series of analyses to better understand the function of each gene. </plain></SENT>
<SENT sid="114" pm="."><plain>For these analyses, we used the following web-based resources: IPA, GeneCards Human Gene Database, HGNC and Gene Ontology (GO). </plain></SENT>
<SENT sid="115" pm="."><plain>The pie chart in Figure 6 contains the symbols for each of the 50 common genes. </plain></SENT>
<SENT sid="116" pm="."><plain>This pie chart is also further divided by the family of each gene and the number of genes per family, which is denoted by the number towards the center of each sector of the pie chart. </plain></SENT>
<SENT sid="117" pm="."><plain>The gene families are color coded and are specified in the legend. </plain></SENT>
<SENT sid="118" pm="."><plain>The following eight families are provided in the figure: ligand-dependent nuclear receptor, peptidase, phosphatase, transporter, ion channel, kinase, transcription regulator, enzymes and others. </plain></SENT>
<SENT sid="119" pm="."><plain>The twenty-four genes included in the “other” group consist of genes that were not classified by IPA. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f006" position="float"><label>Figure 6</label><caption><p><text><SENT sid="120" pm="."><plain>Pie chart of 50 shared biomarkers. </plain></SENT>
<SENT sid="121" pm="."><plain>Each sector of the pie represents the number of genes associated with each function. </plain></SENT>
<SENT sid="122" pm="."><plain>The symbols and number of genes are also provided for each function. </plain></SENT>
<SENT sid="123" pm="."><plain>Genes were filtered for an absolute value log2 ratio ≥1.5 and a significance value of p ≤ 0.05. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g006"/></fig></SecTag><p><text><SENT sid="124" pm="."><plain>Next, we sought to examine the temporal expression kinetics for the genes with known biological functions. </plain></SENT>
<SENT sid="125" pm="."><plain>We found that only 44 of the 50 genes identified had well-characterized biological processes and GO annotations. Figure 7 provides the magnitude of the fold-change in expression for each of these genes as a function of time. </plain></SENT>
<SENT sid="126" pm="."><plain>The asterisks denote genes that have multiple key biological functions. </plain></SENT>
<SENT sid="127" pm="."><plain>The genes include the chaperones that function in response to stress and protein unfolding. </plain></SENT>
<SENT sid="128" pm="."><plain>These genes encode for the following heat shock 70 kDa proteins: HSPA6, HSPA1L and HSPA1A/A1B. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f007" position="float"><label>Figure 7</label><caption><p><text><SENT sid="129" pm="."><plain>The temporal expression kinetics for the genes with known gene ontology (GO). </plain></SENT>
<SENT sid="130" pm="."><plain>Asterisks indicate the genes with more than one biological process. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g007"/></fig></SecTag><p><text><SENT sid="131" pm="."><plain>Additional genes responsible for the response to stress or heat are CDHR1 (cadherin-related family member 1), TUB (tubby protein homolog), NOX1 (NADPH oxidase 1) and IRF1 (interferon regulatory factor 1). </plain></SENT>
<SENT sid="132" pm="."><plain>Two genes—PSMB2 (proteasome subunit beta type 2) and UBA6 (ubiquitin-like modifier activating enzyme 6)—play roles in protein ubiquitination. </plain></SENT>
<SENT sid="133" pm="."><plain>CDHR1, ARHGEF40 (Rho guanine nucleotide exchange factor (GEF) 40), CD9 (CD9 molecule), DST (dystonin), LRRN2 (leucine rich repeat neuronal 2) and PCDH11X/Y (protocadherin 11 Y-linked) support cell adhesion. </plain></SENT>
<SENT sid="134" pm="."><plain>ALPK1 (alpha-kinase 1), AGK (acylglycerol kinase), CAMK2B (calcium/calmodulin-dependent protein kinase II beta), MYLK (myosin light chain kinase) and TLK2 (tousled-like kinase 2) assist in phosphorylation, whereas, GRID1 (glutamate receptor delta-1 subunit), KCNK10 (potassium channel subfamily K member 10), ARL4C (ADP-ribosylation factor-like 4), HBA1/HBA2 (hemoglobin alpha 1), PITPNC1 (cytoplasmic phosphatidylinositol transfer protein 1), CAMK2B and NOX1 support the transport function. </plain></SENT>
<SENT sid="135" pm="."><plain>In addition, CADM2 (cell adhesion molecule 2), HIST1H2AG (histone cluster 1, H2ag), NEBL (nebulette) and IGHA1 play roles in junction organization, nucleosome assembly, actin filament length and immune response, respectively. </plain></SENT>
<SENT sid="136" pm="."><plain>Furthermore, as indicated in Figure 7, some of the above mentioned genes and the remaining ones are involved in processes related to homeostasis response. </plain></SENT>
<SENT sid="137" pm="."><plain>These include regulation of transcription, apoptosis, metabolism and signal transduction related-genes. </plain></SENT>
</text></p><p><text><SENT sid="138" pm="."><plain>The gene families related to the unique genes or the genes shared between each two time points, as well as the number of genes per each family are illustrated in the pie charts in Figure 8. </plain></SENT>
<SENT sid="139" pm="."><plain>The gene families included those mentioned for the 50 common genes in addition to other gene families, such as G-protein coupled receptor, growth factor, cytokine, translation regulator and transmembrane receptor family. </plain></SENT>
<SENT sid="140" pm="."><plain>The genes classified by IPA as “other” were omitted in this representation. </plain></SENT>
<SENT sid="141" pm="."><plain>A list of all these genes and fold-change following heat-shock in the different interval of recovery is added as tables in the supplemental materials. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f008" position="float"><label>Figure 8</label><caption><p><text><SENT sid="142" pm="."><plain>Gene family of the genes that are unique or are shared at two time points. </plain></SENT>
<SENT sid="143" pm="."><plain>The pie chart sectors represent the number of genes associated with each function indicated in the legend. </plain></SENT>
<SENT sid="144" pm="."><plain>The numbers of these genes are indicated for each function. </plain></SENT>
<SENT sid="145" pm="."><plain>The genes classified by IPA as “other” were not included in this representation. </plain></SENT>
<SENT sid="146" pm="."><plain>Genes were filtered for an absolute value log2 ratio ≥1.5 and a significance value of p ≤ 0.05. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g008"/></fig></SecTag><p><text><SENT sid="147" pm="."><plain>In Figure 9, we highlight a set of genes from the unique genes list that are recognized to play roles in cellular stress response. </plain></SENT>
<SENT sid="148" pm="."><plain>These include genes involved as heat shock proteins and genes supporting DNA damage and repair, inflammation and apoptosis. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f009" position="float"><label>Figure 9</label><caption><p><text><SENT sid="149" pm="."><plain>Gene expression profiles for a set of unique genes involved in several well-characterized pathways of the cellular stress response. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g009"/></fig></SecTag></sec><sec><title><text><SENT sid="150" pm="."><plain>2.5. </plain></SENT>
<SENT sid="151" pm="."><plain>Pathway Analysis of Microarray Analyzed Data </plain></SENT>
</text></title><p><text><SENT sid="152" pm="."><plain>We next used IPA to analyze the metabolic and signaling pathways that are affected in response to heat stress following the three post-heat time points. </plain></SENT>
<SENT sid="153" pm="."><plain>We found that at 0 h, 33 of 247 canonical pathways were expressed with statistical significance, defined as [(−log(p-value) ≥ 1.3 or p-value ≤ 0.05] (Table 1). </plain></SENT>
<SENT sid="154" pm="."><plain>At 4 h post-heat, 19 out of 198 scored Ingenuity Canonical Pathways had significant likelihood (Table 2). </plain></SENT>
<SENT sid="155" pm="."><plain>At 24 h post-heat, IPA scored 229 Ingenuity Canonical Pathways, of which 36 had significant p-values (Table 3). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="cells-02-00224-t001" position="float"><object-id pub-id-type="pii">cells-02-00224-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="156" pm="."><plain>Significant canonical pathways at 0 h post-heat exposure. </plain></SENT>
<SENT sid="157" pm="."><plain>Two-hundred seventy-four Ingenuity Canonical Pathways were scored at 0 h post-heat exposure; only the 33 listed pathways fit the cut-off of p-value ≤ 0.05. </plain></SENT>
</text></p></caption><table frame="hsides" rules="all"><thead><tr><th style="border-top:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Ingenuity Canonical Pathways </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>−log(p-value) </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>Ratio </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain># of Molecules </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>IL-12 Signaling and Production in Macrophages </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>4.66 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>0.118 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>16 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>Glucocorticoid Receptor Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>1.83 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>0.061 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>16 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>1.41 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>0.054 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>16 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>Production of Nitric Oxide and Reactive Oxygen Species in Macrophages </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>1.85 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>0.070 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>Clathrin-Mediated Endocytosis Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>1.80 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>0.069 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>Dopamine-DARPP32 Feedback in cAMP Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>1.46 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>0.067 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>NF-κB Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>1.42 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>0.065 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>RAR Activation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>1.35 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>0.063 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>Neuropathic Pain Signaling in Dorsal Horn Neurons </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>2.35 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>0.094 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>Type II Diabetes Mellitus Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>2.07 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>0.079 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>Virus Entry via Endocytic Pathways </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>2.28 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>0.098 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Synaptic Long-Term Potentiation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>1.88 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>0.087 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>fMLP Signaling in Neutrophils </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>1.78 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>0.077 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>PKCθ Signaling in T-lymphocytes </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>1.64 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>0.071 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>2.29 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>0.104 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>T-cell Receptor Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>1.61 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>0.078 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>iCOS-iCOSL Signaling in T Helper Cells </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>1.45 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>0.071 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>Rac Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>1.45 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>0.068 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>Pancreatic Adenocarcinoma Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>1.41 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>0.070 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>Renin-Angiotensin Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>1.33 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>0.070 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>Erythropoietin Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>1.95 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>0.095 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>Macropinocytosis Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>1.92 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>0.092 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>NF-κB Activation by Viruses </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>1.76 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>0.089 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>Ceramide Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>1.62 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>0.085 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>RANK Signaling in Osteoclasts </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>1.42 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>0.076 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>Calcium-induced T-lymphocyte Apoptosis </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>1.72 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>0.098 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>Growth Hormone Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>1.42 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>0.085 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>Complement System </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>2.24 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>0.152 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>MSP-RON Signaling Pathway </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>1.66 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>0.109 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>Cell Cycle: G1/S Checkpoint Regulation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>1.33 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>0.085 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>Role of CHK Proteins in Cell Cycle Checkpoint Control </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>1.50 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>0.114 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>IL-9 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>1.46 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>0.105 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td style="border-bottom:solid thin" align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>April Mediated Signaling </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>1.31 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>0.095 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>4 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="cells-02-00224-t002" position="float"><object-id pub-id-type="pii">cells-02-00224-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="294" pm="."><plain>Significant canonical pathways in 4 h post-heat exposure. </plain></SENT>
<SENT sid="295" pm="."><plain>198 Ingenuity Canonical Pathways were scored at 4 h post-heat exposure; only the 19 listed pathways fit the cut-off of p-value ≤ 0.05. </plain></SENT>
</text></p></caption><table frame="hsides" rules="all"><thead><tr><th style="border-top:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>Ingenuity Canonical Pathways </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>−log(p-value) </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>Ratio </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain># of Molecules </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>Leukocyte Extravasation Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>2.58 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>0.127 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>24 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>Huntington’s Disease Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>2.39 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>0.114 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>26 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>Tight Junction Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>2.34 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>0.127 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>20 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>Bladder Cancer Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>2.15 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>0.144 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>VDR/RXR Activation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>2.12 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>0.152 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>ATM Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>2.04 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>0.167 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>Coagulation System </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>2.02 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>0.200 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Colorectal Cancer Metastasis Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>1.90 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>0.107 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>26 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>Wnt/β-catenin Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>1.90 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>0.118 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>20 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>Cyclins and Cell Cycle Regulation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>1.76 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>0.126 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>1.70 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>0.096 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>30 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>Nur77 Signaling in T-lymphocytes </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>1.62 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>0.140 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>IL-17A Signaling in Gastric Cells </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>1.57 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>0.200 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>Cell Cycle: G1/S Checkpoint Regulation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>1.49 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>0.136 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>IL-17A Signaling in Fibroblasts </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>1.49 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>0.154 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>Nitrogen Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>1.49 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>0.171 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>Production of Nitric Oxide and Reactive Oxygen Species in Macrophages </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>1.37 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>0.103 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>19 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>Ceramide Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>1.35 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>0.122 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td style="border-bottom:solid thin" align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>Aldosterone Signaling in Epithelial Cells </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>1.35 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>0.106 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>17 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="cells-02-00224-t003" position="float"><object-id pub-id-type="pii">cells-02-00224-t003_Table 3</object-id><label>Table 3</label><caption><p><text><SENT sid="376" pm="."><plain>Significant canonical pathways at 24 h post-heat exposure. </plain></SENT>
<SENT sid="377" pm="."><plain>229 Ingenuity Canonical Pathways were scored at 24 h post-heat exposure; only the 36 listed pathways fit the cut-off of p-value ≤ 0.05. </plain></SENT>
</text></p></caption><table frame="hsides" rules="all"><thead><tr><th style="border-top:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>Ingenuity Canonical Pathways </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>−log(p-value) </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>Ratio </plain></SENT>
</text></th><th style="border-top:solid thin" align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain># of Molecules </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>Aryl Hydrocarbon Receptor Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>4.33 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>0.170 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Linoleic Acid Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>2.78 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>0.197 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>Role of IL-17A in Psoriasis </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>2.74 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>0.385 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>Bladder Cancer Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>2.72 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>0.167 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>14 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>Oncostatin M Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>2.52 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>0.235 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>TREM1 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>2.39 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>0.189 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Cell Cycle: G1/S Checkpoint Regulation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>2.21 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>0.169 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>2.08 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>0.149 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>Role of CHK Proteins in Cell Cycle Checkpoint Control </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>2.00 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>0.200 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>Glucocorticoid Receptor Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>1.94 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>0.108 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>29 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>Atherosclerosis Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>1.90 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>0.128 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>15 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>Cell Cycle: G2/M DNA Damage Checkpoint Regulation </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>1.88 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>0.167 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>Amino sugars Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>1.88 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>0.159 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>Metabolism of Xenobiotics by Cytochrome P450 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>1.86 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>0.148 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>IL-8 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>1.77 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>0.118 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>20 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>Airway Pathology in Chronic Obstructive Pulmonary Disease </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>1.75 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>0.375 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>LPS/IL-1 Mediated Inhibition of RXR Function </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>1.74 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>0.112 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>22 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>Chronic Myeloid Leukemia Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>1.71 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>0.127 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>Arachidonic Acid Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>1.71 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>0.137 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>Sphingosine-1-phosphate Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>1.70 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>0.126 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>14 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>Hereditary Breast Cancer Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>1.67 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>0.125 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>14 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>Leukocyte Extravasation Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>1.66 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>0.116 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>21 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>Role of BRCA1 in DNA Damage Response </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>1.65 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>0.153 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>Pancreatic Adenocarcinoma Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>1.61 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>0.123 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>Role of IL-17F in Allergic Inflammatory Airway Diseases </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>1.56 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>0.167 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>IL-10 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>1.53 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>0.139 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>IL-22 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>1.52 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>0.208 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Cellular Effects of Sildenafil (Viagra) </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>1.47 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>0.121 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>15 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>Inhibition of Angiogenesis by TSP1 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>1.47 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>0.182 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>Role of JAK Family Kinases in IL-6-type Cytokine Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>1.45 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>0.192 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>Tryptophan Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>1.45 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>0.127 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>Purine Metabolism </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>1.41 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>0.106 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>27 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>Parkinson’s Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>1.39 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>0.222 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>p53 Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>1.35 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>0.126 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>cAMP-Mediated Signaling </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>1.33 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>0.107 </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>22 </plain></SENT>
</text></td></tr><tr><td style="border-bottom:solid thin" align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>IL-15 Production </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>1.32 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>0.172 </plain></SENT>
</text></td><td style="border-bottom:solid thin" align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>4 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="526" pm="."><plain>Subsequently, in order to highlight the pathways more relevant to cellular stress response, we further refined our analysis by excluding signaling pathway categories, such as cancer, cardiovascular and nervous system signaling, toxicity list and disease-specific pathways, in addition to non-skin cell-type-specific canonical pathways. Figure 10 shows a refined presentation of the top canonical pathways for each post-heat recovery time point. </plain></SENT>
<SENT sid="527" pm="."><plain>For the cell cycle, the G1/S checkpoint regulation pathway was affected in all three time points. The ceramide signaling pathway was affected in both 0 h and 4 h. </plain></SENT>
<SENT sid="528" pm="."><plain>The glucocorticoid receptor signaling pathway and role of CHK proteins in cell cycle checkpoint control were affected in both 0 h and 24 h. </plain></SENT>
<SENT sid="529" pm="."><plain>All the remaining canonical pathways involved were exclusive to a particular time point. </plain></SENT>
<SENT sid="530" pm="."><plain>Notably, although most of the canonical pathways in each post-heat time point were unique, they actually serve overlapping top cellular functions. </plain></SENT>
<SENT sid="531" pm="."><plain>The canonical pathways playing a role in cellular function and maintenance that were affected in 0 h post-heat consisted of MSP-RON signaling, Rac signaling pathways and two endocytosis pathways. </plain></SENT>
<SENT sid="532" pm="."><plain>Both endocytosis pathways, namely, macropinocytosis and clathrin-mediated endocytosis signaling pathways, play important roles in plasma membrane reorganization, internalization of extracellular molecules and in transduction of signals within the cell and between cells. </plain></SENT>
<SENT sid="533" pm="."><plain>Deregulation of seven and 13 genes in macropinocytosis signaling and clathrin-mediated endocytosis signaling, respectively, starting 0 h post-heat, implicate an immediate effect of heat shock on the plasma membrane and signal transduction. </plain></SENT>
<SENT sid="534" pm="."><plain>Macropinocytosis depends on signaling to the actin cytoskeleton, such as the Rac signaling pathway, which was also affected at 0 h post-heat, with eight deregulated genes, including the Rac activator, TIAM1 (T-lymphoma invasion and metastasis 1). </plain></SENT>
<SENT sid="535" pm="."><plain>Immediately, TIAM1 mRNA showed more than a 4-fold increase. </plain></SENT>
<SENT sid="536" pm="."><plain>Interestingly, TIAM1 has been reported to prevent cell death in heat-stressed wild-type murine keratinocytes, since the TIAM1 knock-out cells displayed increased apoptosis [20]. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="cells-02-00224-f010" position="float"><label>Figure 10</label><caption><p><text><SENT sid="537" pm="."><plain>Classification of differentially expressed genes into various cellular stress response implicated canonical pathways. </plain></SENT>
<SENT sid="538" pm="."><plain>The [−log(p-value)] is the maximum p-value for all of the genes in each particular canonical pathway family. </plain></SENT>
<SENT sid="539" pm="."><plain>The ratio plot indicates the number of the genes expressed at each time point relative to the total number of genes in that particular canonical pathway group. </plain></SENT>
</text></p></caption><graphic xlink:href="cells-02-00224-g010"/></fig></SecTag><p><text><SENT sid="540" pm="."><plain>Of the canonical pathways affected at 4 h post-heat, tight junction signaling plays a role in cellular function and maintenance, whereas those affected at 24 h post-heat included amino sugar metabolism and cAMP-mediated signaling pathways. </plain></SENT>
<SENT sid="541" pm="."><plain>The latter is also important in controlling cellular assembly and organization in addition to post-translational modification. </plain></SENT>
<SENT sid="542" pm="."><plain>Notably, tight junction signaling also plays a role in cellular assembly and organization in addition to cell-to-cell signaling and interaction. </plain></SENT>
<SENT sid="543" pm="."><plain>The 0 h time-point post-heat affected pathways playing roles in the regulation of cellular development and/or in cellular growth and proliferation comprised cell cycle G1/S checkpoint regulation, the glucocorticoid receptor, IL-9, NF-κB, April-mediated and growth hormone signaling. </plain></SENT>
<SENT sid="544" pm="."><plain>The 24 h post-heat assessment showed that pathways regulating these functions are the cell cycle G1/S checkpoint regulation, the glucocorticoid receptor, IL-10 signaling, the role of JAK family kinases in IL-6-type cytokine signaling and purine metabolism, while affected pathways at 4 h post-heat included cell cycle G1/S checkpoint regulation only. </plain></SENT>
<SENT sid="545" pm="."><plain>The cell cycle control function is regulated by two pathways at 0 h post-heat, namely cell cycle G1/S checkpoint regulation and growth hormone signaling. </plain></SENT>
</text></p><p><text><SENT sid="546" pm="."><plain>Whereas, four of the canonical pathways affected at 4 h post-heat (ATM signaling, cyclins, cell cycle regulation, nitrogen metabolism and cell cycle G1/S checkpoint regulation) function in the control of cell cycle progression. </plain></SENT>
<SENT sid="547" pm="."><plain>Six of the 17 canonical pathways affected at 24 h post-heat play a role in cell cycle control. </plain></SENT>
<SENT sid="548" pm="."><plain>These are aryl hydrocarbon receptor signaling, cell cycle G1/S checkpoint regulation, the role of CHK proteins in cell cycle checkpoint control, cell cycle G2/M DNA damage checkpoint regulation and the two metabolic pathways, linoleic acid metabolism and tryptophan metabolism. </plain></SENT>
<SENT sid="549" pm="."><plain>Cell death, on the other hand, is controlled by the ceramide signaling pathway that was affected at 0 and 4 h post-heat and by the related sphingosine-1-phosphate signaling pathway, as well as by the aryl hydrocarbon receptor signaling and cell cycle G2/M DNA damage checkpoint regulation, which were affected at 24 h post-heat. </plain></SENT>
<SENT sid="550" pm="."><plain>Interestingly, the canonical pathways involved in inflammatory response were only affected at 24 h post-heat. </plain></SENT>
<SENT sid="551" pm="."><plain>They consist of IL-10 and IL-22 signaling. </plain></SENT>
<SENT sid="552" pm="."><plain>The DNA replication, recombination and repair function involves the role of CHK proteins in cell cycle checkpoint control that was affected at 4 h and 24 h post-heat, the ATM signaling pathway that was affected at 4 h post-heat only and cell cycle G2/M DNA damage checkpoint regulation that was affected at 24 h post-heat only. </plain></SENT>
</text></p></sec></sec></SecTag><sec><title><text><SENT sid="553" pm="."><plain>3. </plain></SENT>
<SENT sid="554" pm="."><plain>Experimental Section </plain></SENT>
</text></title><sec><title><text><SENT sid="555" pm="."><plain>3.1. </plain></SENT>
<SENT sid="556" pm="."><plain>Cell Culture Conditions and Hyperthermia Stress Protocol </plain></SENT>
</text></title><p><text><SENT sid="557" pm="."><plain>HEK were cultured in EpiLife® medium containing supplement S7, as per the manufacturer’s recommendations (Life Technologies). </plain></SENT>
<SENT sid="558" pm="."><plain>For the heat-shock experiment, cells were put in 1.7 mL tubes (1.0 × 106 cells/tube) that were sealed with Para-film® and placed in a circulating water bath at 44 °C for 40 min. </plain></SENT>
<SENT sid="559" pm="."><plain>No significant change in pH was observed. </plain></SENT>
<SENT sid="560" pm="."><plain>Following hyperthermia, cells were either harvested within 5 min or were first allowed to recover in the incubator at 37 °C/95% humidity/5% CO2 for 4 h or for 24 h. </plain></SENT>
<SENT sid="561" pm="."><plain>Control cells harvested alongside the heat-treated cells were also put in 1.7 mL tubes (1.0 × 106 cells/tube), but were maintained at all time in an incubator at 37 °C/95% humidity/5% CO2. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="562" pm="."><plain>3.2. </plain></SENT>
<SENT sid="563" pm="."><plain>Cellular Viability Assays </plain></SENT>
</text></title><p><text><SENT sid="564" pm="."><plain>Viability was evaluated at different post-exposure time points using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays (ATCC, Manassas, VA, USA). </plain></SENT>
<SENT sid="565" pm="."><plain>In brief, HEKs were exposed to hyperthermic stress, then were incubated for 5 min (0 h post-heat), 4 h (4 h post-heat) or 24 h (24 h post-heat). </plain></SENT>
<SENT sid="566" pm="."><plain>Subsequently, MTT reagents and detergents were added, as per the manufacturer’s instructions. </plain></SENT>
<SENT sid="567" pm="."><plain>Absorbance readings were measured at 570 nm with a Synergy HT Plate Reader (Biotech, Winooski, VT, USA). </plain></SENT>
<SENT sid="568" pm="."><plain>Absorbance readings were also measured for a ladder of serial dilutions (103–106 cells) in culture medium. </plain></SENT>
<SENT sid="569" pm="."><plain>Absorbance values were plotted versus the cell number, and these curves were used to determine the number of viable cells in each well. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="570" pm="."><plain>3.3. </plain></SENT>
<SENT sid="571" pm="."><plain>RNA Isolation and Normalization </plain></SENT>
</text></title><p><text><SENT sid="572" pm="."><plain>RNA was extracted from the heat-treated and control cells using a RNeasy Mini-Kit (Qiagen), according to the manufactures instructions. </plain></SENT>
<SENT sid="573" pm="."><plain>RNA extraction was performed at three different time intervals as follows: within 5 min following heat-shock (0 h post-heat), after a 4 h recovery period at 37 °C (4 h post-heat) or after a 24 h recovery period at 37 °C (24 h post-heat). </plain></SENT>
<SENT sid="574" pm="."><plain>At each time point, the RNA concentration was assessed on a NanoDrop Spectrophotometer (NanoDrop Technologies), and the quality was measured on a 2100 Bioanalyzer™ (Agilent Technologies). </plain></SENT>
<SENT sid="575" pm="."><plain>RNA samples with a RNA Integrity Number greater than 9.5 were subjected to microarray analysis. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="576" pm="."><plain>3.4. </plain></SENT>
<SENT sid="577" pm="."><plain>Microarray Data Analysis </plain></SENT>
</text></title><p><text><SENT sid="578" pm="."><plain>Expression analysis was performed for each time point in triplicates (three control and three heat-shock treated) using the Affymetrix GeneChip® Human Genome U133 (HG-U133) plus 2.0 Array that contains 54,675 probe sets. </plain></SENT>
<SENT sid="579" pm="."><plain>Briefly, two micrograms of RNA were used for preparation of biotin-labeled targets (cRNA) using MessageAmp™-based protocols (Ambion, Inc.). </plain></SENT>
<SENT sid="580" pm="."><plain>Labeled cRNA was fragmented (0.5 μg/μL per reaction) and was used for array hybridization and washing. </plain></SENT>
<SENT sid="581" pm="."><plain>The cRNA was mixed with a hybridization cocktail, heated to 99 °C for 5 min and then incubated at 45 °C for 5 min. </plain></SENT>
<SENT sid="582" pm="."><plain>Hybridization arrays were conducted for 16 h in an Affymetrix Model 640 hybridization oven (45 °C, 60 rpm). </plain></SENT>
<SENT sid="583" pm="."><plain>Arrays were washed and stained on an FS450 Fluidics station and were scanned on a GeneChip® Scanner 3000 7G. </plain></SENT>
<SENT sid="584" pm="."><plain>Image signal data, detection calls and annotations were generated for every gene using the Affymetrix Statistical Algorithm MAS 5.0 (GeneChip® Operating Software v1.3). </plain></SENT>
<SENT sid="585" pm="."><plain>A log2 transformation was conducted and a Student’s t-test was performed for comparison of the two groups (control and heat-shocked). </plain></SENT>
<SENT sid="586" pm="."><plain>We conducted multiple testing correction—Benjamini and Hochberg—to determine the false discovery rate, and statistical significant genes were identified using Bonferroni correction procedures (−log10 pcutoff &gt; 6.04) [21]. </plain></SENT>
</text></p><p><text><SENT sid="587" pm="."><plain>For interpretation of the results, the Ingenuity Pathways Analysis tool (IPA version 8.7, Ingenuity® Systems Inc., Redwood City, CA, USA; [22]) was used. </plain></SENT>
<SENT sid="588" pm="."><plain>IPA is a web-based software application, which enables filtering and dataset comparisons, to identify biological mechanisms, pathways and functions most relevant to experimental datasets or differentially expressed genes. </plain></SENT>
<SENT sid="589" pm="."><plain>The cut-off criteria for our IPA analysis were: an absolute value of log2 ratio ≥1.5 and a p-value ≤0.05. </plain></SENT>
<SENT sid="590" pm="."><plain>Other web-based resources, such as the GeneCards Human Gene Database [23], The HUGO Gene Nomenclature Committee (HGNC, [24]) and the Gene Ontology [25] were also used to further supplement the analysis. </plain></SENT>
<SENT sid="591" pm="."><plain>The targets identified in the microarray study were validated using qRT-PCR. </plain></SENT>
<SENT sid="592" pm="."><plain>Runs were performed using TaqMan® RNA-to-CT™ 1-Step Kits and TaqMan® Assays for: HSPA6 and GAPDH (Applied Biosystems). </plain></SENT>
<SENT sid="593" pm="."><plain>Calibrator RNA was used as the control (Cell Applications Inc.). </plain></SENT>
<SENT sid="594" pm="."><plain>All assays were performed by Asuragen Services. </plain></SENT>
</text></p></sec></sec><SecTag type="CONCL"><sec><title><text><SENT sid="595" pm="."><plain>4. </plain></SENT>
<SENT sid="596" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="597" pm="."><plain>In this study, we examined the temporal gene expression kinetics for HEK cells exposed to hyperthermic stress. </plain></SENT>
<SENT sid="598" pm="."><plain>Collectively, our results demonstrate that hyperthermic stress triggers a rapid, robust and extensive transcriptional response in HEK cells. </plain></SENT>
<SENT sid="599" pm="."><plain>The temporal kinetics expression data show that this cellular response is immediately activated in response to stress and is sustained for many hours after exposure. </plain></SENT>
<SENT sid="600" pm="."><plain>Specifically, we show that the number of upregulated genes increased in logarithmic fashion as a function of time, ranging from 466 at 0 h, 872 at 4 h and up to 1,127 at 24 h. </plain></SENT>
<SENT sid="601" pm="."><plain>This finding is consistent with previous in vivo studies, which show that HSP70 expression is bi-phasic and peaks at both 12 h and 24 h post-exposure [5,7,8]. </plain></SENT>
<SENT sid="602" pm="."><plain>However, this data is in contrast to previous in vitro reports, which show that the number of regulated genes is maximal roughly 4 to 12 h post-exposure [3,4,5]. </plain></SENT>
<SENT sid="603" pm="."><plain>Furthermore, in this study, we show that many of the genes activated at 24 h encode for chemokines that play central roles in inflammation (i.e., IL-8, IL-10, IL-22, IL-15 and JAK family kinases). </plain></SENT>
<SENT sid="604" pm="."><plain>This suggests that the second expression peak at 24 h is likely due to cellular inflammation. </plain></SENT>
</text></p><p><text><SENT sid="605" pm="."><plain>We identified a large group of diverse heat-inducible genes in this work. </plain></SENT>
<SENT sid="606" pm="."><plain>The temporal kinetics data shows that each individual gene exhibits distinct expression profiles, which vary dramatically in magnitude, onset time and duration of expression. </plain></SENT>
<SENT sid="607" pm="."><plain>From the data, we determined that the heat-inducible genes can be grouped according to their temporal expression phases. </plain></SENT>
<SENT sid="608" pm="."><plain>The first group belongs to an immediate-expression phase consisting of genes that are rapidly expressed shortly (i.e., 5–20 min) after exposure to hyperthermic stress. </plain></SENT>
<SENT sid="609" pm="."><plain>The second group consists of genes expressed several minutes up to 4 h post exposure, and the third group can be considered an “adaption or recovery phase” that occurs 4 h to 24 h post exposure. </plain></SENT>
</text></p><p><text><SENT sid="610" pm="."><plain>The majority of genes expressed during the immediate expression phase encode for proteins involved in molecular transport, cellular growth and heat shock response. </plain></SENT>
<SENT sid="611" pm="."><plain>One notable molecular transport gene is HBA1/HBA2, which functions to facilitate the delivery of oxygen. </plain></SENT>
<SENT sid="612" pm="."><plain>Another interesting finding is that only the well characterized HSPs (i.e., HSP40 and HSP70) are expressed at the early time points, while the smaller HSPs and chaperonins (HSPE1, HSP60; HSPE1, HSP10; HSPB2, HSP27) are expressed at roughly 24 h post-exposure. </plain></SENT>
<SENT sid="613" pm="."><plain>Furthermore, other HSPs, such as HSPH1 (HSP105), which function primarily to prevent protein aggregation, exhibit maximal expression at the 4 h time-point. </plain></SENT>
<SENT sid="614" pm="."><plain>This data strongly supports that each particular type of HSP exhibits expression kinetics that appear to be directly correlated with the function that is required at each time point. </plain></SENT>
<SENT sid="615" pm="."><plain>In summary, these data provide valuable new insights that give us a much clearer picture of the genes and intracellular signaling pathways that are triggered in human epithelial keratinocytes exposed to hyperthermic stress. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="616" pm="."><plain>This study was supported by the Air Force Office of Scientific Research LRIR entitled “Coupling of terahertz radiation to intracellular biomolecules for non-contact control and activation of adaptive cellular responses.” The ideas and opinions presented here are those of the authors and not those of the US Air Force. </plain></SENT>
</text></text4fund></p></ack></SecTag><notes><title>Conflict of Interest</title><p>The authors declare no conflict of interest.</p></notes><SecTag type="REF"><ref-list><title>References</title><ref id="B1-cells-02-00224"><text><SENT sid="617" pm="."><plain>1. SchreckR.AlbermannK.BaeuerleP.A. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review) Free Radic. </plain></SENT>
<SENT sid="618" pm="."><plain>Res. </plain></SENT>
<SENT sid="619" pm="."><plain>Commun. 1992 17 221 237 10.3109/10715769209079515 1473734 </plain></SENT>
</text></ref><ref id="B2-cells-02-00224"><text><SENT sid="620" pm="."><plain>2. WilminkG.J.GrundtJ.E. Invited review article: Current state of research on biological effects of terahertz radiation J. </plain></SENT>
<SENT sid="621" pm="."><plain>Infrared. </plain></SENT>
<SENT sid="622" pm="."><plain>Millim. </plain></SENT>
<SENT sid="623" pm="."><plain>Te. 2011 32 1074 1122 10.1007/s10762-011-9794-5  </plain></SENT>
</text></ref><ref id="B3-cells-02-00224"><text><SENT sid="624" pm="."><plain>3. WilminkG.J.OpalenikS.R.BeckhamJ.T.AbrahamA.A.NanneyL.B.Mahadevan-JansenA.DavidsonJ.M.JansenE.D. Molecular imaging-assisted optimization of hsp70 expression during laser-induced thermal preconditioning for wound repair enhancement J. </plain></SENT>
<SENT sid="625" pm="."><plain>Invest. </plain></SENT>
<SENT sid="626" pm="."><plain>Dermatol. 2009 129 205 216 10.1038/jid.2008.175 18580963 </plain></SENT>
</text></ref><ref id="B4-cells-02-00224"><text><SENT sid="627" pm="."><plain>4. WilminkG.J.OpalenikS.R.BeckhamJ.T.DavidsonJ.M.JansenE.D. Assessing laser-tissue damage with bioluminescent imaging J. </plain></SENT>
<SENT sid="628" pm="."><plain>Biomed. </plain></SENT>
<SENT sid="629" pm="."><plain>Opt. 2006 11 041114 10.1117/1.2339012 16965142 </plain></SENT>
</text></ref><ref id="B5-cells-02-00224"><text><SENT sid="630" pm="."><plain>5. WilminkG.J.OpalenikS.R.BeckhamJ.T.MackanosM.A.NanneyL.B.ContagC.H.DavidsonJ.M.JansenE.D. In-vivo optical imaging of hsp70 expression to assess collateral tissue damage associated with infrared laser ablation of skin J. </plain></SENT>
<SENT sid="631" pm="."><plain>Biomed. </plain></SENT>
<SENT sid="632" pm="."><plain>Opt. 2008 13 054066 10.1117/1.2992594 19021444 </plain></SENT>
</text></ref><ref id="B6-cells-02-00224"><text><SENT sid="633" pm="."><plain>6. WilminkG.J.RivestB.D.RothC.C.IbeyB.L.PayneJ.A.CundinL.X.GrundtJ.E.PeraltaX.MixonD.G.RoachW.P. In vitro investigation of the biological effects associated with human dermal fibroblasts exposed to 2.52 THz radiation Laser. </plain></SENT>
<SENT sid="634" pm="."><plain>Surg. </plain></SENT>
<SENT sid="635" pm="."><plain>Med. 2011 43 152 163 10.1002/lsm.20960  </plain></SENT>
</text></ref><ref id="B7-cells-02-00224"><text><SENT sid="636" pm="."><plain>7. BeckhamJ.T.WilminkG.J.MackanosM.A.TakahashiK.ContagC.H.TakahashiT.JansenE.D. Role of HSP70 in cellular thermotolerance Laser. </plain></SENT>
<SENT sid="637" pm="."><plain>Surg. </plain></SENT>
<SENT sid="638" pm="."><plain>Med. 2008 40 704 715 10.1002/lsm.20713  </plain></SENT>
</text></ref><ref id="B8-cells-02-00224"><text><SENT sid="639" pm="."><plain>8. BeckhamJ.T.WilminkG.J.OpalenikS.R.MackanosM.A.AbrahamA.A.TakahashiK.ContagC.H.TakahashiT.JansenE.D. Microarray analysis of cellular thermotolerance Laser. </plain></SENT>
<SENT sid="640" pm="."><plain>Surg. </plain></SENT>
<SENT sid="641" pm="."><plain>Med. 2010 42 752 765 10.1002/lsm.20963  </plain></SENT>
</text></ref><ref id="B9-cells-02-00224"><text><SENT sid="642" pm="."><plain>9. KabakovA.E.BudagovaK.R.LatchmanD.S.KampingaH.H. Stressful preconditioning and HSP70 overexpression attenuate proteotoxicity of cellular ATP depletion Am. </plain></SENT>
<SENT sid="643" pm="."><plain>J. </plain></SENT>
<SENT sid="644" pm="."><plain>Physiol. </plain></SENT>
<SENT sid="645" pm="."><plain>Cell Physiol. 2002 283 C521 C534 12107062 </plain></SENT>
</text></ref><ref id="B10-cells-02-00224"><text><SENT sid="646" pm="."><plain>10. WilminkG.J.RothC.C.IbeyB.L.KetchumN.BernhardJ.CernaC.Z.RoachW.P. Identification of microRNAs associated with hyperthermia-induced cellular stress response Cell Stress Chaperon. 2010 15 1027 1038 10.1007/s12192-010-0189-7  </plain></SENT>
</text></ref><ref id="B11-cells-02-00224"><text><SENT sid="647" pm="."><plain>11. RichterK.HaslbeckM.BuchnerJ. The heat shock response: Life on the verge of death Mol. </plain></SENT>
<SENT sid="648" pm="."><plain>Cell 2010 40 253 266 10.1016/j.molcel.2010.10.006 20965420 </plain></SENT>
</text></ref><ref id="B12-cells-02-00224"><text><SENT sid="649" pm="."><plain>12. KultzD. Evolution of the cellular stress proteome: From monophyletic origin to ubiquitous function J. </plain></SENT>
<SENT sid="650" pm="."><plain>Exp. </plain></SENT>
<SENT sid="651" pm="."><plain>Biol. 2003 206 3119 3124 10.1242/jeb.00549 12909693 </plain></SENT>
</text></ref><ref id="B13-cells-02-00224"><text><SENT sid="652" pm="."><plain>13. KultzD. Molecular and evolutionary basis of the cellular stress response Annu. </plain></SENT>
<SENT sid="653" pm="."><plain>Rev. </plain></SENT>
<SENT sid="654" pm="."><plain>Physiol. 2005 67 225 257 10.1146/annurev.physiol.67.040403.103635 15709958 </plain></SENT>
</text></ref><ref id="B14-cells-02-00224"><text><SENT sid="655" pm="."><plain>14. OttoA.I.RiouL.MarionnetC.MoriT.SarasinA.MagnaldoT. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients Cancer Res. 1999 59 1212 1218 10096550 </plain></SENT>
</text></ref><ref id="B15-cells-02-00224"><text><SENT sid="656" pm="."><plain>15. SestoA. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays Proc. </plain></SENT>
<SENT sid="657" pm="."><plain>Natl. </plain></SENT>
<SENT sid="658" pm="."><plain>Acad. </plain></SENT>
<SENT sid="659" pm="."><plain>Sci. </plain></SENT>
<SENT sid="660" pm="."><plain>USA 2002 99 2965 2970 10.1073/pnas.052678999 11867738 </plain></SENT>
</text></ref><ref id="B16-cells-02-00224"><text><SENT sid="661" pm="."><plain>16. LiD.TuriT.G.SchuckA.FreedbergI.M.KhitrovG.BlumenbergM. Rays and arrays: The transcriptional program in the response of human epidermal keratinocytes to UVB illumination FASEB J. 2001 15 2533 2535 11641260 </plain></SENT>
</text></ref><ref id="B17-cells-02-00224"><text><SENT sid="662" pm="."><plain>17. HowellB.G.WangB.FreedI.MamelakA.J.WatanabeH.SauderD.N. Microarray analysis of UVB-regulated genes in keratinocytes: Downregulation of angiogenesis inhibitor thrombospondin-1 J. </plain></SENT>
<SENT sid="663" pm="."><plain>Dermatol. </plain></SENT>
<SENT sid="664" pm="."><plain>Sci. 2004 34 185 194 10.1016/j.jdermsci.2004.01.004 15113588 </plain></SENT>
</text></ref><ref id="B18-cells-02-00224"><text><SENT sid="665" pm="."><plain>18. BenderK.BlattnerC.KnebelA.IordanovM.HerrlichP.RahmsdorfH.J. UV-induced signal transduction J. </plain></SENT>
<SENT sid="666" pm="."><plain>Photochem. </plain></SENT>
<SENT sid="667" pm="."><plain>Photobiol. </plain></SENT>
<SENT sid="668" pm="."><plain>B Biol. 1997 37 1 17 10.1016/S1011-1344(96)07459-3  </plain></SENT>
</text></ref><ref id="B19-cells-02-00224"><text><SENT sid="669" pm="."><plain>19. TyrrellR.M. Activation of mammalian gene expression by the UV component of sunlight—From models to reality BioEssays 1996 18 139 148 10.1002/bies.950180210 8851047 </plain></SENT>
</text></ref><ref id="B20-cells-02-00224"><text><SENT sid="670" pm="."><plain>20. RygielT.P.MertensA.E.StrumaneK.van der KammenR.CollardJ.G. The Rac activator Tiam1 prevents keratinocytes apoptosis by controlling ROS-mediated ERK phosphorylation J. </plain></SENT>
<SENT sid="671" pm="."><plain>Cell Sci. 2008 121 1183 1192 10.1242/jcs.017194 18349077 </plain></SENT>
</text></ref><ref id="B21-cells-02-00224"><text><SENT sid="672" pm="."><plain>21. BenjaminiY.HochbergY. Controlling the false discovery rate: A practical and powerful approach to multiple testing J. </plain></SENT>
<SENT sid="673" pm="."><plain>Roy. </plain></SENT>
<SENT sid="674" pm="."><plain>Stat. </plain></SENT>
<SENT sid="675" pm="."><plain>Soc. </plain></SENT>
<SENT sid="676" pm="."><plain>Ser. </plain></SENT>
<SENT sid="677" pm="."><plain>B 1995 57 289 300  </plain></SENT>
</text></ref><ref id="B22-cells-02-00224"><text><SENT sid="678" pm="."><plain>22. Ingenuity Systems, Inc. </plain></SENT>
<SENT sid="679" pm="."><plain>Home Page Available online:<ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com/">http://www.ingenuity.com/</ext-link> (accessed on 1 August 2012)  </plain></SENT>
</text></ref><ref id="B23-cells-02-00224"><text><SENT sid="680" pm="."><plain>23. GeneCards® Home Page Available online:<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org/">http://www.genecards.org/</ext-link> (accessed on 1 August 2012)  </plain></SENT>
</text></ref><ref id="B24-cells-02-00224"><text><SENT sid="681" pm="."><plain>24. HGNC, HUGO Gene Nomenclature Committee Home Page Available online:<ext-link ext-link-type="uri" xlink:href="http://www.genenames.org/">http://www.genenames.org/</ext-link> (accessed on 1 August 2012)  </plain></SENT>
</text></ref><ref id="B25-cells-02-00224"><text><SENT sid="682" pm="."><plain>25. The Gene Ontology Home Page Available online:<ext-link ext-link-type="uri" xlink:href="http://geneontology.org/">http://geneontology.org/</ext-link> (accessed on 1 August 2012)  </plain></SENT>
</text></ref></ref-list></SecTag><SecTag type="APPENDIX"><app-group><app><title>Supplementary Files</title><supplementary-material content-type="local-data" id="cells-02-00224-s001"><label>Supplementary File 1</label><caption><p><text><SENT sid="683" pm="."><plain>Supplementary Table (PDF, 2889 KB) </plain></SENT>
</text></p></caption><media xlink:href="cells-02-00224-s001.pdf"><caption><p><text><SENT sid="684" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></app></app-group></SecTag></back></article>
